$260/t not sure if that is truely the going price for lithium....

First 14 Last

Share
Profile

Follow
Mark06

1,859 Posts.

238

05/01/17

08:30

Post #: 21686774
Share

Originally posted by Maigret1 ↑

http://www.*.co.uk/columns/sp-angel/26813/today-s-market-view-metminco-ltd-and-solgold-plc

another perspective....

Lithium:
Birimian Gold – offer of A$107.5m for its Bougouni ‘Golamina’ asset values A$469 (US$341) per lithium resource tonne

The offer by Shandong Mingrui Group appears to be bang on the average value for lithium resources which looks like a nice deal for Shandong considering the relatively high grade of Birimian’s Golamina resource at 1.8-2.2% lithium (Li2O) for 229,000t of contained lithium metal.
The weighted average on our table of lithium producers is US$350/t though this is skewed by a relatively high valuation for Nemaska Lithium in Canada.
If we strip out the value of Nemaska Lithium then our weighted average value for lithium resources falls to US$260/t of lithium.
We suspect Shandong’s offer is based on the potential for increasing the Golamina lithium resource which is still a bit on the small size compared with others in our peer group.
Elsewhere Albemarle Corp, the US lithium and speciality chemicals group has just completed its acquisition of Jiangli New Materials in China for US$145m. The Jiangli New Material assets are focussed on the production of battery-grade lithium hydroxide and lithium carbonate have a total lithium salts capacity of 15,000tpa which Albemarle will raise to 20-25,000tpa.

Expand

$260/t not sure if that is truely the going price for lithium. Galaxy resources signed a 2017 price of $950/t am I correct?

BGS Price at posting: 37.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MAY

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

LU7

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

PIQ

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

REA

UK-based Rightmove knocks back REA Group's acquisition proposal